InvestorsObserver
×
News Home

Is Adial Pharmaceuticals Inc (ADIL) a Stock to Watch After Gaining 12.25% This Week?

Thursday, November 02, 2023 09:56 AM | InvestorsObserver Analysts

Mentioned in this article

Is Adial Pharmaceuticals Inc (ADIL) a Stock to Watch After Gaining 12.25% This Week?

Adial Pharmaceuticals Inc (ADIL) stock is up 12.25% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Adial Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ADIL!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ADIL Stock Today?

Adial Pharmaceuticals Inc (ADIL) stock is trading at $2.29 as of 9:49 AM on Thursday, Nov 2, a rise of $0.11, or 5.05% from the previous closing price of $2.18. The stock has traded between $2.29 and $2.31 so far today. Volume today is below average. So far 1,180 shares have traded compared to average volume of 70,252 shares.

More About Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Click Here to get the full Stock Report for Adial Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App